Full Court puts injector pen patent appeal on fast track
Appeals 2019-01-17 2:03 pmBy Cat Fredenburgh | Melbourne
Please login to bookmark Close

The Full Federal Court has expedited an appeal filed Christmas Eve by Sanofi-Aventis of a ruling that denied its bid to block Alphapharm from listing an insulin injector pen on the Pharmaceutical Benefit Scheme.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au